Nasdaq:US$9.39 (-0.19) | HKEX:HK$16.36 (-0.66) | AIM:£1.51 (-0.08)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 9 Oct 2013

Chi-Med’s Pharmaceutical R&D Business – Analyst & Investor Briefing